AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹300 Cr | ₹261 Cr | ₹155 Cr | ₹0.00 Cr |
Adjustment | ₹95 Cr | ₹83 Cr | ₹52 Cr | - |
Changes In working Capital | ₹-122 Cr | ₹-32 Cr | ₹-230 Cr | ₹0.00 Cr |
Cash Flow after changes in Working Capital | ₹273 Cr | ₹312 Cr | ₹-23 Cr | - |
Cash Flow from Operating Activities | ₹216 Cr | ₹250 Cr | ₹-44 Cr | - |
Cash Flow from Investing Activities | ₹-215 Cr | ₹-158 Cr | ₹-139 Cr | - |
Cash Flow from Financing Activities | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
Net Cash Inflow / Outflow | ₹12 Cr | ₹-71 Cr | ₹78 Cr | - |
Opening Cash & Cash Equivalents | ₹12 Cr | ₹83 Cr | ₹5.33 Cr | ₹0.25 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹24 Cr | ₹12 Cr | ₹83 Cr | ₹0.25 Cr |
Compare Cashflow Statement of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,609.7 Cr | 1.9% | 13% | 57.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 1.9% |
13% |
57.5% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses